Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth.
Begovich K, Schoolmeesters A, Rajapakse N, Martinez-Terroba E, Kumar M, Shakya A, Lai C, Greene S, Whitefield B, Okano A, Mali V, Huang S, Chourasia AH, Fung L.
Begovich K, et al. Among authors: chourasia ah.
Mol Cancer Ther. 2024 Apr 2;23(4):407-420. doi: 10.1158/1535-7163.MCT-23-0513.
Mol Cancer Ther. 2024.
PMID: 38224565